IDEXX Laboratories Inc

NAS:IDXXHealthcareCBOE:SPESGNASDAQ:NQUSLG

$555.81−0.81%At closeAt close · Mon 19 Oct · ≈ AED 2,041.21 · Market cap $43.79B · Next earnings Mon 2 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	58.0%	58.8%	59.5%	59.8%	61.0%	61.8%	—	—
Operating margin	25.7%	29.0%	26.7%	30.0%	29.0%	31.6%	31.6%	+0.0 pts
Net margin	21.5%	23.2%	20.2%	23.1%	22.8%	24.6%	24.6%	+0.0 pts
EBITDA margin	29.3%	32.3%	30.1%	33.3%	32.7%	34.1%	—	—
Return on equity	92.0%	107.9%	111.6%	56.9%	55.7%	66.0%	66.0%	+0.0 pts
Return on assets	25.4%	30.6%	24.7%	25.9%	27.0%	31.6%	31.6%	+0.0 pts
Return on capital employed	40.6%	55.7%	59.5%	47.5%	50.7%	61.8%	—	—
Debt / equity	1.6×	1.5×	2.4×	0.7×	0.6×	0.7×	0.7×	+0.0%
Debt / assets	43.7%	42.3%	53.5%	32.7%	30.0%	32.1%	—	—
Interest coverage	21.0×	31.3×	22.5×	26.4×	36.2×	35.5×	—	—
Current ratio	1.8×	1.3×	0.9×	1.6×	1.3×	1.2×	1.2×	+0.0%
Quick ratio	1.5×	0.9×	0.6×	1.2×	1.0×	0.8×	—	—
Cash ratio	0.7×	0.2×	0.1×	0.5×	0.3×	0.2×	0.2×	+0.0%
Asset turnover	1.2×	1.3×	1.2×	1.1×	1.2×	1.3×	—	—
Inventory turnover	5.4×	4.9×	3.7×	3.9×	4.0×	4.4×	—	—
Receivables turnover	7.2×	7.6×	6.9×	6.9×	6.9×	6.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.